Tianjin Huanhu Hospital
Tianjin, Tianjin Municipality, China
NCT Number: NCT06213870
The goal of this observational study is to learn about the role of MRI evaluation based on FVH-DWI mismatch principle in preoperative evaluation of endovascular thrombolectomy.
The main questions it aims to answer are:
* The consistency between MRI and perfusion examination in determining EVT indications. * The consistency of functional independence rate between patients screening with MRI and perfusion.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Tianjin, Tianjin Municipality, China
MRI is the preferred imaging mode in many centers,for the diffusion-weighted imaging (DWI) sequences are highly sensitive to acute cerebral ischemia.In addition, MRI does not require intravenous contrast agent, which is simpler and more popular than perfusion.Fluid-attenuated inversion recovery (FLAIR)sequence vascular hyperintensity(FVH) is defined as focal, serpentine, or linear hyperintensity that usually occurs in the Sylvian fissure and is associated with large-vessel occlusion or stenosis.The FVH-DWI mismatch(defined as the FVH extended beyond the boundary of the DWI cortical lesions) had been confirmed has excellent sensitivity and specificity in predicting PWI-DWI mismatch.It is not well established whether MRI based on FVH-DWI mismatch and perfusion evaluation differ in determining EVT indications and outcomes.
The main objectives of this study were to (1) determine the proportion of patients eligible for EVT surgery selected by MRI based on FVH-DWI mismatch vs perfusion in a large multicenter registry and (2) identify statistical differences in functional outcomes and safety outcomes between the two evaluation methods.
Patients with ischemic stroke with anterior-circulation large-vessel occlusion in the late (6-24 h) time window from real-world, single center retrospective cohort registry were compared.In the MRI group, patients with FVH-DWI mismatch underwent EVT surgery or were otherwise treated with medication.In the perfusion group, surgical indications referring the DEFUSE 3 standards. The primary outcome was 90-day functional independence rate (mRS score ≤2) in all patients included(including EVT patient and medication patients).Safety outcomes included symptomatic intracranial hemorrhage (sICH), and 90-day mortality.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
In the MRI group, patients with FVH-DWI mismatch underwent EVT surgery or were otherwise treated with medication.
In the perfusion group, patients who meet the criteria of DEFUSE3 will receive EVT surgery, otherwise receive medication.
Time frame: 90days
Proportion of patients with mRS0-2 scores at 90 days
Time frame: 90days
according to the definition proposed by European Cooperative Acute Stroke Study III: intracranial hemorrhage that is associated with deterioration in NIHSS of 4 or more points and the main reason for neurological deterioration
Time frame: 90days
Death from any cause within 90 days
Tianjin Huanhu Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06700824
Brain Diseases, Cardiovascular Diseases
Bordeaux, France
View Trial DetailsNCT06953427
Acute Cerebral Ischemia, Age Factors
Taichung, Taiwan
View Trial DetailsNCT05684172
Acute Ischemic Stroke, Brain Diseases
Hefei, Anhui, China
View Trial DetailsNCT06290076
Acute Ischemic Stroke, Brain Diseases
Beijing, Beijing Municipality, China
View Trial Details